Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Silicon Valley Cardiology is a California cardiovascular medical group focused on the diagnosis and treatment of heart rhythm disorders, coronary disease, vascular disease, and other cardiac conditions. The practice emphasizes clinical cardiology, electrophysiology, interventional cardiology, outpatient diagnostic testing, and inpatient cardiovascular procedures in the San Francisco Bay Area. Its website highlights expertise in atrial fibrillation ablation, pacemaker and implantable cardioverter-defibrillator management, coronary interventions, venous disease care, and advanced cardiac imaging. The group originated in 1984, operated for many years as Cardiovascular Medicine and Cardiac Arrhythmias, and rebranded as Silicon Valley Cardiology in 2011. In 2017, it merged with the Palo Alto Medical Foundation Medical Group while continuing to use the Silicon Valley Cardiology name in patient-facing materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Silicon Valley Cardiology.